YM-3711

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameYM-3711
Drug Alias NameDNA vaccine targeting amyloid-beta species and amyloidogenic peptides (Tokyo Metropolitan Institute of Medical Science)IgL-A-beta-x4-Fc-IL-4 vaccineSecond generation DNA vaccines (Tokyo Metropolitan Institute of Medical Science)YM-3711
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTokyoto Igaku Kenkyu Kiko
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunotherapy Development IncTokyoto Igaku Kenkyu KikoVitruvian Biomedical
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A